Article
-
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
NEW DAY trial of ILUVIEN for DME does not meet primary endpoint, post-hoc analysis suggests potential benefits
3 Things You Should Know About Interventional Glaucoma Comanagement
Annexon completes enrollment in phase 3 ARCHER II trial of vonaprument for geographic atrophy
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Scuba divers and surfers face dual light exposure that may accelerate AMD
Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence